neuropeptide AF (Human) [5682]



neuropeptide AF (Human)


SMILES CC(C)CC(NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(C)N)C(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(Cc1ccccc1)C(=O)O
InChIKey YPBGORNZMUQFSF-UHFFFAOYSA-N
Sequence AGEGLNSQFWSLAAPQRF
HELM PEPTIDE1{A.G.E.G.L.N.S.Q.F.W.S.L.A.A.P.Q.R.F}$$$$

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Log P None
Molecular weight (Da) None

Database connections

No bioactivity data available.

neuropeptide AF (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Compound is not listed as a drug.